Efficacy of ESHAP versus ICE plus dexamethasone (DICE) as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma

Efficacy of ESHAP versus ICE plus dexamethasone (DICE) as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma

AbstractObjectives To compare the efficacy and side effects of salvage chemotherapy between etoposide, methylprednisolone, cytarabine and cisplatin (ESHAP) and ifosfamide, carboplatin and etoposide plus dexamethasone (DICE) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL).Methods Med...

Full description

Bibliographic Details
Main Authors: Pattamaporn Boonlerd, Adisak Tantiworawit, Lalita Norasetthada, Chatree Chai-Adisaksopha, Teerachat Punnachet, Nonthakorn Hantrakun, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Ekarat Rattarittamrong
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
Relapsed or refractory diffuse large B-cell lymphoma
diffuse large B-cell lymphoma
lymphoma
ICE chemotherapy
ESHAP chemotherapy
DICE chemotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2261109

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2261109

Similar Items